Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Adrenergic Receptors: ɑ Subtype01:31

Adrenergic Receptors: ɑ Subtype

Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of pulsed electric field technology on whey protein isolate.

Journal of dairy science·2026
Same author

Discovery of a Novel Non-MET-Mediated Otoprotective Compound Against Aminoglycoside-Induced Ototoxicity.

bioRxiv : the preprint server for biology·2026
Same author

Influence of Pulsed Electric Field Technology on Functionality and Protein Structure of Evaporated Skim Milk and Nonfat Dry Milk.

International journal of molecular sciences·2026
Same author

Single amino acid substitutions modulate the function of α9α10 nicotinic acetylcholine receptor.

International journal of biological macromolecules·2026
Same author

Limb Dominance Does Not Affect Y-Balance Performance in Young Athletes 12 Weeks After Anterior Cruciate Ligament Reconstruction.

International journal of sports physical therapy·2026
Same author

Putative α7-selective ligands interact with α9-containing nicotinic acetylcholine receptors and modulate immune functions of human mononuclear phagocytes.

Frontiers in immunology·2026

Related Experiment Video

Updated: Jun 21, 2026

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
11:44

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Published on: October 2, 2018

Structural basis for alpha-conotoxin potency and selectivity.

Matt Turner1, Seth Eidemiller, Bryan Martin

  • 1Department of Chemistry and Biochemistry, Boise State University, ID 83725-1520, USA.

Bioorganic & Medicinal Chemistry
|July 25, 2009
PubMed
Summary
This summary is machine-generated.

A new alpha-conotoxin MII analog, alpha-CTx MII[E11A], shows high specificity for alpha(6) nicotinic acetylcholine receptors (nAChRs) implicated in Parkinson's disease. Its structure reveals insights for designing targeted therapies.

More Related Videos

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

Related Experiment Videos

Last Updated: Jun 21, 2026

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities
11:44

Synthesis and Structure Determination of µ-Conotoxin PIIIA Isomers with Different Disulfide Connectivities

Published on: October 2, 2018

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators
10:30

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

Area of Science:

  • Neuroscience
  • Pharmacology
  • Structural Biology

Background:

  • Parkinson's disease involves altered alpha(6)beta(2) nicotinic acetylcholine receptors (nAChRs) in the brain.
  • Alpha-conotoxin MII (alpha-CTx MII) probes these receptors but lacks subtype specificity.

Purpose of the Study:

  • To determine the 3D structure of a novel alpha-CTx MII analog, alpha-CTx MII[E11A].
  • To understand how alpha-CTx MII[E11A] achieves high affinity and selectivity for specific alpha(6) nAChR subtypes relevant to Parkinson's disease.

Main Methods:

  • Two-dimensional (1)H NMR spectroscopy was used to determine the solution structure of alpha-CTx MII[E11A].
  • Structural comparisons were made with other alpha-conotoxin family members.

Main Results:

  • The 3D structure of alpha-CTx MII[E11A] was resolved with high precision.
  • Alpha-CTx MII[E11A] exhibits 500-5300-fold discrimination between alpha(6) * nAChR subtypes.
  • It binds with femtomolar affinity to the high-affinity alpha(6) nAChR subtype, which is lost in Parkinson's disease.

Conclusions:

  • The increased hydrophobic area of alpha-CTx MII[E11A] likely contributes to its high affinity and subtype selectivity.
  • This structural information facilitates the design of novel analogs targeting alpha(6) * nAChR interfaces.
  • Findings aid in understanding nAChR roles in dopamine regulation and Parkinson's disease.